查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2016034

血液分離術市場報告：按組件、產品、技術、流程、應用、最終用戶和地區分類（2026-2034 年）

Apheresis Market Report by Component (Plasma, Platelets, Leukocytes, Lymphocytes, RBC's ), Product, Technology, Procedure, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2025年全球血液分離市場規模達33億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到57億美元，2026年至2034年的複合年成長率為6.01%。

血液分離術是一種將捐血成分（如紅血球、白血球、血小板和血漿）分離出來，並用於治療各種疾病的醫療程序。它可用於治療鐮狀細胞貧血症，鐮狀。血液分離術也可用於增稠血液和清除損害器官功能的異常白血球。此外，由於它對治療血液癌症和血液疾病（如重症肌無力和血栓性血小板低下紫斑症紫斑症）有效，因此血液分離術在全球的血液採集中心、醫院和門診診所廣泛應用。

血液分離術市場趨勢：

對血漿分離術治療各種疾病（例如自體免疫溶血性貧血、急性播散性腦脊髓炎和新生兒心臟狼瘡）的需求不斷成長，是推動市場發展的主要因素之一。此外，在全球範圍內，血漿分離術在燒燙傷和創傷患者治療中的應用也日益廣泛。這與快速發展的醫療產業共同促進了市場成長。此外，主要市場公司加大研發投入，致力於研發用於治療嚴重阻塞性動脈硬化的改良型血液淨化設備，也對市場產生了正面影響。同時，用於治療原發性免疫力缺乏和血友病的血漿需求不斷成長，為行業投資者提供了極具吸引力的成長機會。此外，血漿分離術在治療方法血栓性血小板減少性紫斑症、溶血性尿毒症候群、藥物中毒、自體免疫免疫疾病、敗血症和肝功能衰竭等多種疾病的血栓性血小板低下紫斑症，也提振了市場前景。最後，大眾對血液分離術益處的認知不斷提高，也促進了市場成長。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球血液分離市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依組件分類

  • 血漿（血漿分離法）
  • 血小板（血小板分離法）
  • 白血球（白血球分離或白血球單採）
  • 淋巴球（淋巴球分離法或淋巴球單採）
  • 紅血球（紅血球分離法）

第7章 市場區隔：依產品分類

  • 裝置
  • 一次性產品和試劑
  • 軟體

第8章 市場區隔：依技術分類

  • 離心分離
  • 膜分離
  • 選擇性吸附

第9章 市場區隔：依治療方式分類

  • 供體/自動化血漿分離術
  • 治療性血液分離術

第10章 市場區隔：依應用領域分類

  • 腎臟疾病
  • 血液疾病
  • 神經系統疾病
  • 自體免疫疾病
  • 其他

第11章 市場區隔：依最終用戶分類

  • 血液中心
  • 醫院
  • 其他

第12章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第13章 SWOT 分析

第14章：價值鏈分析

第15章：波特五力分析

第16章：價格分析

第17章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Asahi Kasei Medical Co. Ltd.
    • B. Braun SE
    • Fresenius Kabi AG
    • Haemonetics Corporation
    • Haier Biomedical
    • Infomed SA
    • Kaneka Medical Europe NV
    • Medica SPA
    • Miltenyi Biotec
    • SB-Kawasumi Laboratories, Inc.
    • Terumo BCT, Inc.
Product Code: SR112026A6477

The global apheresis market size reached USD 3.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.7 Billion by 2034, exhibiting a growth rate (CAGR) of 6.01% during 2026-2034.

Apheresis is a procedure of separating donated blood components, such as red blood cells (RBCs), white blood cells (WBCs), platelets, and plasma, to treat various diseases. It assists in treating sickle cell disease wherein red blood cells (RBCs) are shaped abnormally and cannot carry oxygen through the body. It is also employed to remove abnormal white blood cells (WBCs) that thicken the blood and interfere with organ function. In addition, as it aids in treating blood cancers and blood disorders, such as myasthenia gravis and thrombotic thrombocytopenic purpura (TTP), apheresis is widely used in blood collection centers, hospitals, and ambulatory centers across the globe.

APHERESIS MARKET TRENDS:

The growing demand for apheresis to treat various diseases, such as autoimmune hemolytic anemia, acute disseminated encephalomyelitis, and cardiac neonatal lupus, represents one of the key factors driving the market. Besides this, there is a rise in the utilization of apheresis to collect plasma for treating burnt and trauma patients across the globe. This, along with the burgeoning healthcare industry, is contributing to the growth of the market. Moreover, increasing investments by key market players in research and development (R&D) activities to introduce an enhanced blood purification device that treats severe forms of arteriosclerosis obliterans is positively influencing the market. In addition, the rising demand for source plasma to treat primary immunodeficiency and hemophilia is offering lucrative growth opportunities to industry investors. Apart from this, the growing employment of apheresis as a therapy for various diseases, such as thrombotic thrombocytopenic purpura, hemolytic uremic syndrome , drug toxicities, autoimmune disease, sepsis, and fulminant hepatic failure, is offering a positive market outlook. Additionally, the increasing awareness among the masses about the benefits of apheresis is bolstering the growth of the market.

KEY MARKET SEGMENTATION:

Breakup by Component:

  • Plasma (Plasmapheresis)
  • Platelets (Plateletpheresis)
  • Leukocytes (Leukapheresis or Leukopheresis)
  • Lymphocytes (Lymphopheresis or Lymphapheresis)
  • RBC's (Erythropheresis)

Breakup by Product:

  • Devices
  • Disposables and Reagents
  • Software

Breakup by Technology:

  • Centrifugation
  • Membrane Separation
  • Selective Adsorption

Breakup by Procedure:

  • Donor/Automated Apheresis
  • Therapeutic Apheresis

Breakup by Application:

  • Renal Disorders
  • Hematological Disorders
  • Neurological Disorders
  • Autoimmune Disorders
  • Others

Breakup by End User:

  • Blood Centers
  • Hospitals
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The report provides a comprehensive analysis of the competitive landscape in the global apheresis market with detailed profiles of all major companies, including:

  • Asahi Kasei Medical Co. Ltd.
  • B. Braun SE
  • Fresenius Kabi AG
  • Haemonetics Corporation
  • Haier Biomedical
  • Infomed SA
  • Kaneka Medical Europe N.V.
  • Medica SPA
  • Miltenyi Biotec
  • SB-Kawasumi Laboratories, Inc.
  • Terumo BCT, Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global apheresis market in 2025?

2. What is the expected growth rate of the global apheresis market during 2026-2034?

3. What are the key factors driving the global apheresis market?

4. What has been the impact of COVID-19 on the global apheresis market?

5. What is the breakup of the global apheresis market based on the component?

6. What is the breakup of the global apheresis market based on the product?

7. What is the breakup of the global apheresis market based on the technology?

8. What is the breakup of the global apheresis market based on procedure?

9. What is the breakup of the global apheresis market based on the application?

10. What is the breakup of the global apheresis market based on the end user?

11. What are the key regions in the global apheresis market?

12. Who are the key players/companies in the global apheresis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Apheresis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Plasma (Plasmapheresis)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Platelets (Plateletpheresis)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Leukocytes (Leukapheresis or Leukopheresis)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Lymphocytes (Lymphopheresis or Lymphapheresis)
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 RBC's (Erythropheresis)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Devices
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Disposables and Reagents
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Software
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Centrifugation
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Membrane Separation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Selective Adsorption
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Procedure

  • 9.1 Donor/Automated Apheresis
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Therapeutic Apheresis
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Renal Disorders
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hematological Disorders
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Neurological Disorders
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Autoimmune Disorders
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Others
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 Market Breakup by End User

  • 11.1 Blood Centers
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Hospitals
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Others
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia-Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Price Analysis

17 Competitive Landscape

  • 17.1 Market Structure
  • 17.2 Key Players
  • 17.3 Profiles of Key Players
    • 17.3.1 Asahi Kasei Medical Co. Ltd.
      • 17.3.1.1 Company Overview
      • 17.3.1.2 Product Portfolio
    • 17.3.2 B. Braun SE
      • 17.3.2.1 Company Overview
      • 17.3.2.2 Product Portfolio
      • 17.3.2.3 SWOT Analysis
    • 17.3.3 Fresenius Kabi AG
      • 17.3.3.1 Company Overview
      • 17.3.3.2 Product Portfolio
      • 17.3.3.3 Financials
      • 17.3.3.4 SWOT Analysis
    • 17.3.4 Haemonetics Corporation
      • 17.3.4.1 Company Overview
      • 17.3.4.2 Product Portfolio
      • 17.3.4.3 Financials
      • 17.3.4.4 SWOT Analysis
    • 17.3.5 Haier Biomedical
      • 17.3.5.1 Company Overview
      • 17.3.5.2 Product Portfolio
    • 17.3.6 Infomed SA
      • 17.3.6.1 Company Overview
      • 17.3.6.2 Product Portfolio
      • 17.3.6.3 Financials
      • 17.3.6.4 SWOT Analysis
    • 17.3.7 Kaneka Medical Europe N.V.
      • 17.3.7.1 Company Overview
      • 17.3.7.2 Product Portfolio
      • 17.3.7.3 Financials
      • 17.3.7.4 SWOT Analysis
    • 17.3.8 Medica SPA
      • 17.3.8.1 Company Overview
      • 17.3.8.2 Product Portfolio
      • 17.3.8.3 Financials
    • 17.3.9 Miltenyi Biotec
      • 17.3.9.1 Company Overview
      • 17.3.9.2 Product Portfolio
    • 17.3.10 SB-Kawasumi Laboratories, Inc.
      • 17.3.10.1 Company Overview
      • 17.3.10.2 Product Portfolio
    • 17.3.11 Terumo BCT, Inc.
      • 17.3.11.1 Company Overview
      • 17.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Apheresis Market: Major Drivers and Challenges
  • Figure 2: Global: Apheresis Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Apheresis Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Apheresis Market: Breakup by Component (in %), 2025
  • Figure 5: Global: Apheresis Market: Breakup by Product (in %), 2025
  • Figure 6: Global: Apheresis Market: Breakup by Technology (in %), 2025
  • Figure 7: Global: Apheresis Market: Breakup by Procedure (in %), 2025
  • Figure 8: Global: Apheresis Market: Breakup by Application (in %), 2025
  • Figure 9: Global: Apheresis Market: Breakup by End User (in %), 2025
  • Figure 10: Global: Apheresis Market: Breakup by Region (in %), 2025
  • Figure 11: Global: Apheresis (Plasma (Plasmapheresis)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Apheresis (Plasma (Plasmapheresis)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Apheresis (Platelets (Plateletpheresis)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Apheresis (Platelets (Plateletpheresis)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Apheresis (Leukocytes (Leukapheresis or Leukopheresis)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Apheresis (Leukocytes (Leukapheresis or Leukopheresis)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Apheresis (Lymphocytes (Lymphopheresis or Lymphapheresis)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Apheresis (Lymphocytes (Lymphopheresis or Lymphapheresis)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Apheresis (RBC's (Erythropheresis)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Apheresis (RBC's (Erythropheresis)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Apheresis (Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Apheresis (Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Apheresis (Disposables and Reagents) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Apheresis (Disposables and Reagents) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Apheresis (Software) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Apheresis (Software) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Apheresis (Centrifugation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Apheresis (Centrifugation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Apheresis (Membrane Separation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Apheresis (Membrane Separation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Apheresis (Selective Adsorption) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Apheresis (Selective Adsorption) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Apheresis (Donor/Automated Apheresis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Apheresis (Donor/Automated Apheresis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Apheresis (Therapeutic Apheresis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Apheresis (Therapeutic Apheresis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Apheresis (Renal Disorders) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Apheresis (Renal Disorders) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Apheresis (Hematological Disorders) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Apheresis (Hematological Disorders) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Apheresis (Neurological Disorders) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Apheresis (Neurological Disorders) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Global: Apheresis (Autoimmune Disorders) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Global: Apheresis (Autoimmune Disorders) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Global: Apheresis (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Global: Apheresis (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Global: Apheresis (Blood Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Global: Apheresis (Blood Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Global: Apheresis (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Global: Apheresis (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Global: Apheresis (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Global: Apheresis (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: North America: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: North America: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: United States: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: United States: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Canada: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Canada: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Asia-Pacific: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Asia-Pacific: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: China: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: China: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Japan: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Japan: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: India: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: India: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: South Korea: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: South Korea: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Australia: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Australia: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Indonesia: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Indonesia: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Others: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Others: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Europe: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Europe: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Germany: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Germany: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: France: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: France: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: United Kingdom: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: United Kingdom: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Italy: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Italy: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Spain: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Spain: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 87: Russia: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 88: Russia: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Others: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 90: Others: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 91: Latin America: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 92: Latin America: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 93: Brazil: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 94: Brazil: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 95: Mexico: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 96: Mexico: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 97: Others: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 98: Others: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 99: Middle East and Africa: Apheresis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 100: Middle East and Africa: Apheresis Market: Breakup by Country (in %), 2025
  • Figure 101: Middle East and Africa: Apheresis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 102: Global: Apheresis Industry: SWOT Analysis
  • Figure 103: Global: Apheresis Industry: Value Chain Analysis
  • Figure 104: Global: Apheresis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Apheresis Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Apheresis Market Forecast: Breakup by Component (in Million USD), 2026-2034
  • Table 3: Global: Apheresis Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 4: Global: Apheresis Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 5: Global: Apheresis Market Forecast: Breakup by Procedure (in Million USD), 2026-2034
  • Table 6: Global: Apheresis Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 7: Global: Apheresis Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 8: Global: Apheresis Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 9: Global: Apheresis Market: Competitive Structure
  • Table 10: Global: Apheresis Market: Key Players